Erik Magnus Ohman, MBBS

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 8678A Hafs Bldg, Durham, NC 27710
Phone (919) 681-2069
Email address ohman001@mc.duke.edu

Dr. Ohman, Professor of Medicine, received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland (1984, Fellowship 1984-1987), and completed his training in cardiology at Duke University (1987-1991), where he has remained on faculty. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005 he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.

Dr. Ohman’s clinical and research interests include interventional cardiology and high-risk supported PCI, and treatment of patients with advanced/complex coronary disease. He has researched how to improve patient care through the use of guidelines-based therapies and adherence, and examining global cardiovascular risk and health. He has been a participant on numerous guidelines writing committees, served on the ACC/AHA oversight committee for guidelines development, and has served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health, and a consultant for the FDA Advisory Panel for Cardiovascular Devices. 

Dr. Ohman has published over 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the American Heart Journal and serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology.  He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology. 

Education and Training

  • M.B.B.S., Royal College of Surgeons (Ireland), 1981

Publications

Redfors, Björn, Reza Mohebi, Gennaro Giustino, Shmuel Chen, Harry P. Selker, Holger Thiele, Manesh R. Patel, et al. “Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction.” Circ Cardiovasc Interv 14, no. 2 (February 2021): e009879. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009879.

PMID
33440999
Full Text

Ohman, E Magnus, and Michael G. Nanna. “Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?” J Am Coll Cardiol 77, no. 3 (January 26, 2021): 268–70. https://doi.org/10.1016/j.jacc.2020.11.036.

PMID
33478649
Full Text

Samsky, Marc D., Mitchell W. Krucoff, David A. Morrow, William T. Abraham, Fernando Aguel, Andrew D. Althouse, Eric Chen, et al. “Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.” Am Heart J 230 (December 2020): 93–97. https://doi.org/10.1016/j.ahj.2020.09.015.

PMID
33011148
Full Text

Marquis-Gravel, Guillaume, and E Magnus Ohman. “Towards a better standard for defining high bleeding risk patients: can we now translate this into a better practice?” Eur Heart J 41, no. 38 (October 7, 2020): 3750–52. https://doi.org/10.1093/eurheartj/ehaa699.

PMID
33099277
Full Text

Russo, Juan J., Megha Prasad, Darshan Doshi, Dimitrios Karmpaliotis, Manish A. Parikh, Ziad A. Ali, Jeffrey J. Popma, et al. “Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.” Catheter Cardiovasc Interv 96, no. 4 (October 1, 2020): 764–70. https://doi.org/10.1002/ccd.28557.

PMID
31693292
Full Text

Baber, Usman, George Dangas, Dominick Joseph Angiolillo, David Joel Cohen, Samin Kumar Sharma, Johny Nicolas, Carlo Briguori, et al. “Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.” Eur Heart J 41, no. 37 (October 1, 2020): 3533–45. https://doi.org/10.1093/eurheartj/ehaa670.

PMID
33085967
Full Text

Marquis-Gravel, Guillaume, Megan L. Neely, Marco Valgimigli, Francesco Costa, David Van Klaveren, Rituparna Altner, Deepak L. Bhatt, et al. “Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.” Circ Cardiovasc Qual Outcomes 13, no. 9 (September 2020): e006582. https://doi.org/10.1161/CIRCOUTCOMES.120.006582.

PMID
32862694
Full Text

Yip, Christina, Aruni Seneviratna, Sock-Hwee Tan, Thet Khaing, Siew-Pang Chan, Joshua Loh, Chi-Hang Lee, et al. “Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation.” J Thromb Thrombolysis 50, no. 2 (August 2020): 421–29. https://doi.org/10.1007/s11239-020-02066-y.

PMID
32077007
Full Text

Pages